Wells Fargo & Company Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLXGet Free Report) had its price objective lowered by equities researchers at Wells Fargo & Company from $125.00 to $110.00 in a report released on Wednesday, MarketBeat Ratings reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 2.12% from the company’s current price.

Other analysts have also recently issued reports about the company. Jefferies Financial Group reduced their price target on Clorox from $152.00 to $151.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Morgan Stanley raised their price target on Clorox from $125.00 to $136.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. JPMorgan Chase & Co. raised their price target on Clorox from $114.00 to $117.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. TD Cowen raised their price target on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Finally, Royal Bank Of Canada set a $132.00 price target on Clorox in a report on Wednesday, February 4th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, Clorox presently has an average rating of “Reduce” and an average price target of $115.93.

Check Out Our Latest Stock Analysis on Clorox

Clorox Stock Up 1.9%

CLX opened at $107.72 on Wednesday. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The business has a 50 day simple moving average of $114.31 and a 200-day simple moving average of $111.05. The stock has a market capitalization of $13.02 billion, a P/E ratio of 17.60, a P/E/G ratio of 0.52 and a beta of 0.65. Clorox has a 12 month low of $96.66 and a 12 month high of $143.96.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm’s quarterly revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the business earned $1.55 earnings per share. On average, equities analysts anticipate that Clorox will post 7.15 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clorox

Hedge funds have recently bought and sold shares of the stock. Hudson Bay Capital Management LP purchased a new position in Clorox during the second quarter worth $8,568,000. ProShare Advisors LLC increased its position in Clorox by 11.7% during the third quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock worth $159,922,000 after buying an additional 136,135 shares in the last quarter. Vanguard Personalized Indexing Management LLC increased its position in Clorox by 64.2% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock worth $3,173,000 after buying an additional 10,065 shares in the last quarter. JPMorgan Chase & Co. increased its position in Clorox by 27.0% during the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after buying an additional 197,330 shares in the last quarter. Finally, Brookstone Capital Management boosted its holdings in shares of Clorox by 1,395.4% during the third quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock worth $11,631,000 after purchasing an additional 88,024 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Recommended Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.